Novo Nordisk and AWS bring agentic AI into drug discovery
Novo Nordisk is expanding its use of AWS artificial intelligence tools across drug discovery, including AI agents for target identification, therapy design, and research workflows. Under the agreement announced recently, AWS will become Novo Nordisk’s preferred cloud provider and strategic AI partne
Novo Nordisk is expanding its use of AWS artificial intelligence tools across drug discovery, including AI agents for target identification, therapy design, and research workflows. Under the agreement announced recently, AWS will become Novo Nordisk’s preferred cloud provider and strategic AI partner. The companies have also created a co-innovation hub at Novo Nordisk’s existing London […] The post Novo Nordisk and AWS bring agentic AI into drug discovery appeared first on AI News.
Key Takeaways
- •Novo Nordisk is expanding its use of AWS artificial intelligence tools across drug discovery, including AI agents for target identification, therapy design, and research workflows
- •This story was reported by AI News Daily, covering developments in the news space.
- •AI advancements continue to reshape industries — read the full article on AI News Daily for complete coverage.
📖 Continue reading the full article:
Read Full Article on AI News Daily →
